World's Best Scientists 2026 revealed!
Daniel C. Cattran

Daniel C. Cattran

D-Index & Metrics

Medicine

D-Index
97
Citations
31431
World Ranking
9364
National Ranking
369

Daniel C. Cattran publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Daniel C. Cattran sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 282 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Daniel C. Cattran D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel C. Cattran sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Daniel C. Cattran is affiliated with the University Health Network in Canada. The primary area of their research is in Medicine, with a significant focus on Nephrology. Other notable subfields include Pathology and Forensic Medicine, Hematology, Immunology, and Rheumatology.

Their research concentrates on several key topics, notably:

  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Platelet Disorders and Treatments
  • Systemic Lupus Erythematosus Research
  • Complement system in diseases
  • Autoimmune Bullous Skin Diseases
  • Systemic Sclerosis and Related Diseases

Frequent publication venues for Daniel C. Cattran include:

  • Kidney International
  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • UNC Libraries
  • Clinical Journal of the American Society of Nephrology

Several papers authored or co-authored by Cattran illustrate their research trajectory and collaborations. Key recent papers are:

  • The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis, 2020, Nature Communications
  • Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy, 2022, Kidney International
  • Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy, 2023, Nature Genetics
  • Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification, 2023, Kidney International
  • Why Target the Gut to Treat IgA Nephropathy?, 2020, Kidney International Reports

Daniel C. Cattran has collaborated extensively with several frequent co-authors, including:

  • Sean Barbour
  • Jonathan Barratt
  • Brad H. Rovin
  • Jai Radhakrishnan
  • Detlef Schlöndorff

Best Publications

  • The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

    Ian S.D. Roberts;H. Terence Cook;Stéphan Troyanov;Charles E. Alpers

  • Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu

  • Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

    Hernán Trimarchi;Jonathan Barratt;Daniel C. Cattran;H. Terence Cook

  • Remission of Proteinuria Improves Prognosis in IgA Nephropathy

    Heather N. Reich;Stéphan Troyanov;James W. Scholey;Daniel C. Cattran

  • Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

    W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler

  • Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

    Laurence H. Beck;Fernando Custodio Fervenza;David M. Beck;Ramon G B Bonegio

  • Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

    Daniel C. Cattran;Gerald B. Appel;Lee A. Hebert;Lawrence G. Hunsicker

  • Predicting progression in IgA nephropathy.

    Lukasz P. Bartosik;Ginette Lajoie;Linda Sugar;Daniel C. Cattran

  • The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient.

    Jai Radhakrishnan;Daniel C. Cattran

  • Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

    Rosanna Coppo;Stéphan Troyanov;Shubha Bellur;Daniel Cattran

  • Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy The TESTING Randomized Clinical Trial

    Jicheng Lv;Jicheng Lv;Hong Zhang;Muh Geot Wong;Meg J. Jardine

  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Fernando C. Fervenza;Gerald B. Appel;Sean J. Barbour;Brad H. Rovin

  • A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis

    Daniel C. Cattran;Gerald B. Appel;Lee A. Hebert;Lawrence G. Hunsicker

  • Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

    Andrew S. Levey;Daniel Cattran;Aaron Friedman;W. Greg Miller

  • ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption

    Shazia Ashraf;Heon Yung Gee;Stephanie Woerner;Stephanie Woerner;Letian X. Xie

  • Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy: A Randomized Controlled Trial

    Andrew A. House;Misha Eliasziw;Daniel C. Cattran;David N. Churchill

  • Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

    Sean J Barbour;Rosanna Coppo;Hong Zhang;Zhi-Hong Liu

  • Impact of gender on the renal response to angiotensin II

    Judith A. Miller;Laurie A. Anacta;Daniel C. Cattran

  • Rituximab treatment of idiopathic membranous nephropathy.

    F.C. Fervenza;F.G. Cosio;S.B. Erickson;U. Specks

Frequent Co-Authors

John Feehally
John Feehally University of Leicester
Gerald B. Appel
Gerald B. Appel Columbia University
Agnes B. Fogo
Agnes B. Fogo Vanderbilt University Medical Center
Zhihong Liu
Zhihong Liu Nanjing University
Bruce A. Julian
Bruce A. Julian University of Alabama at Birmingham
Jeffrey B. Kopp
Jeffrey B. Kopp National Institutes of Health
Ian Roberts
Ian Roberts London School of Hygiene & Tropical Medicine
Loreto Gesualdo
Loreto Gesualdo University of Bari Aldo Moro
J. Charles Jennette
J. Charles Jennette University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in the health field is a great way to diversify career options and gain specialized expertise. If you are considering alternatives or advancements beyond a traditional MD, there are several flexible online programs to consider.

For those interested in healthcare leadership, online mha programs affordable offer critical business and management skills needed in today’s hospitals and clinics.

Nursing professionals aiming for the highest level of practice may explore the best online dnp programs, which allow for advanced practice and leadership roles.

If pharmacy is your passion, consider pursuing pharmacy school online as a convenient way to achieve a Doctor of Pharmacy degree and broaden your impact in patient care.

Additionally, there is growing demand for professionals in health data management. Accredited him programs can prepare you for vital roles in electronic health records and information systems.

These online pathways can open doors to leadership, specialty, and technology careers throughout the healthcare sector.

Best Scientists Citing Daniel C. Cattran

Trending Scientists

Recently Published Articles